-

US Intraoperative Neuromonitoring Market Analysis 2020-2024, Featuring Cadwell Industries, Medtronic Plc and NuVasive Inc. - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Intraoperative Neuromonitoring Market in the US 2020-2024" report has been added to ResearchAndMarkets.com's offering.

The intraoperative neuromonitoring market (IONM) in the US is poised to grow by USD 955.33 mn during 2020-2024, progressing at a CAGR of 10% during the forecast period. This report provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current US market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing number of surgeries that require IONM. In addition, rising adoption of remote IONM is anticipated to boost the growth of the intraoperative neuromonitoring market in the US.

Market Segmentation

Type:

  • Insourced IONM
  • Outsourced IONM

Application:

  • Orthopedic And Neurosurgeries
  • Cardiovascular Surgeries
  • ENT Surgeries
  • Other Surgeries

Methodology:

  • Evoked Potential (EP) Monitoring
  • Electroencephalogram (EEG)
  • Electromyography (EMG)

End-user:

  • Hospitals
  • Ambulatory Surgical Centers (ASG)
  • Other End-users

Key trends for intraoperative neuromonitoring market growth

This study identifies rising adoption of remote IONM as the prime reason driving growth in the intraoperative neuromonitoring market in the US during the next few years.

Prominent vendors in the US intraoperative neuromonitoring market

A detailed analysis of around 25 vendors operating in the intraoperative neuromonitoring market in us 2020-2024, including some of the vendors such as Accurate Neuromonitoring LLC, Cadwell Industries Inc., Computational Diagnostics Inc., IntraNerve Neuroscience Holdings LC, Medtronic Plc, Natus Medical Inc., NeuroMonitoring Technologies Inc., Nihon Kohden Corp., NuVasive Inc. and SpecialtyCare Inc. .

Key Topics Covered:

1 Executive Summary

2 Market Landscape

2.1 Market Ecosystem

2.2 Market Characteristics

2.3 Value Chain Analysis

3 Market Sizing

3.1 Market Definition

3.2 Market Segmentation Analysis

3.3 Market Size 2019

3.4 Market Outlook: Forecast 2019-2024

4 Five Forces Analysis

5 Market Segmentation

6 Customer Landscape

7 Geographic Landscape

7.1 Geographic Segmentation

7.2 Geographic Comparison

7.3 Europe - Market Size and Forecast 2019-2024

7.4 North America - Market Size and Forecast 2019-2024

7.5 APAC - Market Size and Forecast 2019-2024

7.6 South America - Market Size and Forecast 2019-2024

7.7 MEA - Market Size and Forecast 2019-2024

7.8 Key Leading Countries

7.9 Market Opportunity

8 Drivers, Challenges and Trends

8.1 Market Drivers

8.2 Market Challenges

8.3 Market Trends

9 Vendor landscape

9.1 Overview

9.2 Landscape Disruption

10 Vendor Analysis

10.1 Vendors Covered

10.2 Market Positioning of Vendors

11 Appendix

11.1 Scope of the report

11.2 Currency conversion rates for US$

11.3 Research methodology

11.4 Information sources

11.5 List of abbreviations

11.6 List of Exhibits

Companies Mentioned

  • Accurate Neuromonitoring LLC
  • Cadwell Industries Inc.
  • Computational Diagnostics Inc.
  • IntraNerve Neuroscience Holdings LC
  • Medtronic Plc
  • Natus Medical Inc.
  • NeuroMonitoring Technologies Inc.
  • Nihon Kohden Corp.
  • NuVasive Inc.
  • SpecialtyCare Inc.

For more information about this report visit https://www.researchandmarkets.com/r/xsf05j

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Blockchain and Non-Fungible Tokens new Technologies and the Relevant Law Training Course: Core Principles, Smart Contracts, NFTs, and Decentralized Finance Explained (Online Event: May 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Blockchain and Non-Fungible Tokens: Understanding new Technologies and the Relevant Law Training Course (May 20, 2026)" training has been added to ResearchAndMarkets.com's offering. Blockchain is a new technology that could potentially have major impacts in a wide range of industries. It has the potential to dramatically change how business is conducted - but there is no one central authority controlling blockchain, everyone has access to the same information. Are...

Writing Clinical Research with Integrity Training Course: Principles of Medical and Scientific Writing, Including Ethical Standards, Data Integrity, and Plagiarism Prevention (Online: Apr 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Writing Clinical Research with Integrity Training Course (Apr 20, 2026)" training has been added to ResearchAndMarkets.com's offering. This course covers key principles of medical and scientific writing, including ethical standards, data integrity, and plagiarism prevention. Participants will learn how to tailor content for various audiences, structure documents (e.g., manuscripts, protocols), and adhere to writing standards such as clarity, consistency, and correc...

In-Vitro Diagnostic Regulation (EU) 2017/746 Introduction Training Course (Online Event: Apr 16th - Apr 17th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (Apr 16th - Apr 17th, 2026)" training has been added to ResearchAndMarkets.com's offering. The In-Vitro Diagnostic Regulation (EU) 2017/746, which came into force in May 2017 with a transition period of five years, is intended to strengthen the current approval system for in-vitro diagnostics and makes substantial changes to the existing IVD Directive (98/79/EC) legislation. The Regulation in...
Back to Newsroom